Cadex Genomics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer (NCT03892096) | Cadex Genomics | 2019-03-01 |
Track Cadex Genomics automatically
Every clearance here is in the API, with alerts when new ones post.